Trulieve Completes Redomicile from British Columbia to Delaware

Rhea-AI Summary

Trulieve (NYSE: TRLV) completed its previously announced redomicile from British Columbia, Canada to Delaware, United States on August 11, 2026. The move was approved by shareholders on August 5, 2026, received a Final Order from the British Columbia Supreme Court on August 10, 2026, and became effective upon Delaware filings. Trulieve states the U.S. domicile may expand access to U.S. investors and enhance eligibility for broader index inclusion. The company’s subordinate voting shares continue trading on the New York Stock Exchange under ticker “TRLV”.

Positive

• Completed redomicile to Delaware on August 11, 2026
• Shareholder approval obtained on August 5, 2026
• Company cites potential for broader U.S. investor access and index eligibility

Negative

• None.

Market Context

Recent insider activity for TRLV was Net Selling, with 1,699,007 shares sold and 0 bought over 90 da...

Analysis

Recent insider activity for TRLV was Net Selling, with 1,699,007 shares sold and 0 bought over 90 days. That context adds a governance-related risk lens to the completed Delaware redomicile.

Key Figures

Shareholder approval date: August 5, 2026 Final Order date: August 10, 2026 Redomicile completion date: August 11, 2026

3 metrics

Shareholder approval date August 5, 2026 Special Meeting of Shareholders

Final Order date August 10, 2026 British Columbia Supreme Court

Redomicile completion date August 11, 2026 Delaware filings became effective

Historical Context

5 past events · Latest: Aug 07 (Negative)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 07	Q2 earnings report	Negative	-2.8%	Revenue declined year over year and sequentially, while GAAP net loss reached $406 million.
Aug 05	Conference participation	Neutral	-5.1%	The company announced planned participation in the Canaccord Genuity Growth Conference.
Jul 16	Dispensary opening	Positive	-2.5%	Trulieve announced a new medical cannabis dispensary opening in Marco Island, Florida.
Jul 10	Earnings call scheduling	Neutral	-2.5%	The company scheduled its second-quarter 2026 results conference call for August 7.
Jul 10	Corporate recognition	Positive	-2.5%	Trulieve was included among TIME's 1,000 America's Best Companies for 2026.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior company news generally preceded negative price reactions, including events described positively or neutrally.

Key Terms

redomicile, subordinate voting shares

2 terms

redomicile regulatory

"completion of its previously announced plan to redomicile Trulieve Cannabis Corp."

Redomicile is when a company legally moves its “home” from one country or jurisdiction to another while keeping its business operations largely the same. For investors it matters because the move can change tax rules, legal protections, corporate governance, and the ease of trading shares—similar to a person changing their legal residence to gain different benefits or follow different laws, which can affect value and risk.

subordinate voting shares financial

"Following the redomicile, the Company's subordinate voting shares continue to trade"

Subordinate voting shares are a type of company stock that typically carry fewer voting rights than regular shares, meaning holders have less influence over company decisions. They are often used to raise capital while allowing founders or main shareholders to retain control. For investors, understanding the difference helps assess their level of influence in company decisions and the potential risks or benefits of holding different types of shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TALLAHASSEE, Fla., Aug. 11, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the completion of its previously announced plan to redomicile Trulieve Cannabis Corp. from British Columbia, Canada to Delaware, United States.

"Redomiciling to the United States marks an exciting new chapter for our company, expanding access to U.S. investors and enhancing eligibility for broader index inclusion," said Trulieve CEO Kim Rivers. "As one of the industry's leading cannabis operators, we are thrilled to align our corporate structure with where we operate, invest, and serve our patients."

The redomicile was approved by the Company's shareholders at the Special Meeting of Shareholders held on August 5, 2026. The British Columbia Supreme Court issued its Final Order on August 10, 2026, and the Company completed its redomicile to Delaware on August 11, 2026, when the necessary filings were made effective by the State of Delaware.

Following the redomicile, the Company's subordinate voting shares continue to trade on the New York Stock Exchange under the ticker symbol "TRLV".  

Forward-Looking Statements
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from those contained in the forward-looking statements. Risks and uncertainties include, without limitation, the risks and factors discussed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025 and in our periodic reports subsequently filed with the United States Securities and Exchange Commission and in the Company's filings on SEDAR+ at www.sedarplus.ca. There can be no assurance that any forward-looking statements herein will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof and, except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the NYSE under the symbol TRLV. For more information, please visit Trulieve.com.

Facebook: @Trulieve   
Instagram: @Trulieve
X: @Trulieve

Investor and Media Contact
Christine Hersey, Chief Corporate Affairs and Strategy Officer
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-completes-redomicile-from-british-columbia-to-delaware-302848783.html

SOURCE Trulieve Cannabis Corp.

FAQ

What did Trulieve (NYSE: TRLV) announce on August 11, 2026?

Trulieve announced it completed its redomicile from British Columbia, Canada to Delaware, United States on August 11, 2026. According to Trulieve, this follows prior shareholder approval and court authorization, and its subordinate voting shares continue trading on the NYSE under ticker TRLV.

Why did Trulieve (TRLV) redomicile to Delaware from British Columbia?

Trulieve states the redomicile to Delaware aims to expand access to U.S. investors and enhance eligibility for broader index inclusion. According to Trulieve, aligning its corporate structure with the United States better reflects where it operates, invests, and serves its medical cannabis patients.

When was the Trulieve (TRLV) redomicile to Delaware approved and finalized?

Trulieve shareholders approved the redomicile at a Special Meeting on August 5, 2026. The British Columbia Supreme Court issued its Final Order on August 10, 2026. According to Trulieve, the move was completed on August 11, 2026, when Delaware filings became effective.

Does Trulieve’s stock symbol change after its move to Delaware?

Trulieve’s stock symbol does not change after the redomicile. According to Trulieve, its subordinate voting shares continue to trade on the New York Stock Exchange under the existing ticker symbol “TRLV”, providing continuity for current and prospective shareholders.

How might Trulieve’s redomicile to Delaware affect U.S. investors in TRLV?

According to Trulieve, the U.S. redomicile is intended to expand access for U.S. investors and potentially enhance eligibility for broader index inclusion. The company indicates that its corporate structure is now aligned with its primary operating and investment footprint in the United States.

What legal steps were involved in Trulieve (TRLV) completing its redomicile?

The redomicile required shareholder approval and a court order. According to Trulieve, shareholders approved the plan on August 5, 2026, and the British Columbia Supreme Court granted its Final Order on August 10, 2026, before Delaware filings became effective on August 11, 2026.